Here, we examine post-onset diabetes progression in local patients from the Children’s Hospital of Wisconsin and participants in the TrialNet CTLA4-Ig (Abatacept) trial (TN-09) [25]. The gene discussed is CTLA4; the disease is diabetes mellitus.